Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

53.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen.

Parasitology·2007
Same author

Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.

General physiology and biophysics·2007
Same author

Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines.

International journal of clinical pharmacology and therapeutics·2002
Same author

Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

Anti-cancer drug design·2002
Same author

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Same author

Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

General physiology and biophysics·2002

Related Experiment Video

Updated: Dec 11, 2025

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.9K

Cell proliferation in human melanoma.

S Shirakawa, J K Luce, I Tannock

    The Journal of Clinical Investigation
    |June 1, 1970
    PubMed
    Summary

    Melanoma metastases exhibit variable cell proliferation. Tumor cell growth fraction is 20-30%, with significant cell loss occurring, impacting tumor doubling time.

    Area of Science:

    • Oncology
    • Cell Biology
    • Dermatology

    Background:

    • Subcutaneous metastases in melanoma present a complex cellular dynamic.
    • Understanding tumor cell cytokinetics is crucial for predicting melanoma progression.

    Purpose of the Study:

    • To investigate the cell cycle kinetics of subcutaneous melanoma metastases.
    • To determine the growth fraction and cell loss rate in these tumors.

    Main Methods:

    • Utilized pulse labeling with tritiated thymidine in multiple biopsies.
    • Employed computer analysis for cell cycle phase duration (G2, S) and generation time (Te).
    • Assessed growth fraction using continuous/intermittent labeling and computer fitting.

    Main Results:

    More Related Videos

    Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
    08:19

    Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

    Published on: April 22, 2019

    7.4K
    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    16.3K

    Related Experiment Videos

    Last Updated: Dec 11, 2025

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
    08:06

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

    Published on: July 8, 2020

    5.9K
    Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
    08:19

    Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates

    Published on: April 22, 2019

    7.4K
    A 3D Organotypic Melanoma Spheroid Skin Model
    08:49

    A 3D Organotypic Melanoma Spheroid Skin Model

    Published on: May 18, 2018

    16.3K
    • Identified a median G2 period of 5.3 hours and S period of 21 hours.
    • Determined a variable median generation time (Te) of 3 days.
    • Calculated a growth fraction of 20-30% and indicated approximately 70% cell loss.

    Conclusions:

    • Melanoma metastases display significant heterogeneity in proliferation within tumors.
    • High cell loss rates contribute to a slower actual tumor doubling time than theoretically predicted.
    • These findings highlight the dynamic nature of melanoma metastasis and inform potential therapeutic strategies.